Loading…
Based on limited metadata, this FDA Warning Letter issued to Panacea Biotec Limited on September 24, 2020, concerns drug product manufacturing or operations. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in the metadata provided. Further review of the complete Warning Letter would be necessary to identify the specific compliance issues cited.